OMIX

A Phase I Clinical Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Preliminary Pharmacodynamics of HLX22Monoclonal Antibody Injection in Patients with Advanced Solid Tumours Overexpressing HER2

OMIX002997

1Summary
Title A Phase I Clinical Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Preliminary Pharmacodynamics of HLX22Monoclonal Antibody Injection in Patients with Advanced Solid Tumours Overexpressing HER2
Description To evaluate the safety and maximum to leated dose (MTD) of HLX 22 in patients with advanced or metastatic solid tumours which are non-responsive to standard therapies,screening 20 patients, enrolment 11 Patients.
Organism Homo sapiens
Data Type Other Type of Metabolome Data
Data Accessibility Controlled-access
BioProject PRJCA014975
Release Date 2023-02-16
Submitter Yanhua Ding (18343115092@163.com)
Organization The First Hospital of Jilin University
Submission Date 2023-02-15
2Files & Download

HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX002997-01 HLX22-001HER1data 11 Other Type of Metabolome Data 16.1 KB xlsx 0 Controlled
OMIX002997-02 HLX22-001HER2Data 11 Other Type of Metabolome Data 12.4 KB xlsx 0 Controlled
OMIX002997-03 HLX22-001PKDATA 11 Other Type of Metabolome Data 21.9 KB xlsx 0 Controlled
OMIX002997-04 HLX22-001ADA data 11 Other Type of Metabolome Data 11.4 KB xlsx 0 Controlled

Request for this Data View All Released Data of OMIX